Avalyn Pharma Inc. Common Stock

NASDAQ:AVLN

Medical - Pharmaceuticals

Healthcare
$27.69 +1.77%

+$0.52 today

Market cap
$1.23B
Beta
0.00
52W Low $24.15High $32.23

Volume 0.40M

Average 0.51M

AVLN Investing Cash Flow

Net cash used in or generated by investments in assets, acquisitions, and securities.

No reported Investing Cash Flow figures are available to summarize.

Investing Cash Flow history

Currency unavailable · from the cash flow

No Investing Cash Flow data reported for this period type.

Investing Cash Flow vs competitors

How AVLN compares with its peers on the latest reported figures

AVLN Competitors
Investing Cash Flow for AVLN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MNKDMannKind CorporationLTM Mar 2026$292.04M USD+591.2%—80.9%
VCREVicore Pharma Holding ABLTM Jun 2026SEK 103.44M SEK-78.5%—7777.6%
INSMInsmed IncorporatedLTM Jun 2026$82.79M USD-85.3%+23.1%7.3%
GYREGyre Therapeutics, Inc.LTM Mar 2026$5.5M USD-48.6%-67.5%4.7%
AVLNAvalyn Pharma Inc. Common Stock—— ———
Peer median (excluding AVLN) —-63.6%-22.2%44.1%

Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Avalyn Pharma Inc. Common Stock

NASDAQ:AVLN

Intrinsic Alpha fair value

Locked

Current Price

$27.69

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.